Conclusion
PTS is not a rare disease as it was previously considered. It’s rather
misdiagnosed due to its variable symptoms. An immune system trigger is
usually found. The Covid-19 BNT162b2 mRNA vaccine, like other vaccines,
can be associated to PTS with a typical presentation. As COVID-19
vaccination rates increase, it is quite possible that post-vaccination
PTS will increase. Thus, early recognition is essential to initiate
adequate treatment, leading to better recovery without sequelae.